Environmental Toxin Rotenone Drives LRRK2-Mediated Microtubule, Cilia and Proteostasis Disruption in Parkinson’s Disease Model

Read full text
Authors: Dani Flinkman, Prasannakumar Deshpande, Peter James, Eleanor T. Coffey
Cited by: 0
References: 52

Abstract

Abstract Exposure to the environmental toxin rotenone increases risk for Parkinson’s disease (PD). However, protein phosphorylation changes induced by rotenone in neural-derived cells have not been reported. We examined the effect of rotenone on the proteome and phosphoproteome of cortex-derived cultures from wild-type and Lrrk2-/- mouse brains. We also analyzed the phosphoproteome of the PD cadaver brain using a previously unanalyzed dataset. Rotenone alters phosphorylation at 904 sites, most of which are unchanged in Lrrk2-/- cultures. Common targets include proteins that control microtubule stability, vesicular transport, and protein clearance via the autophagosomal/lysosomal pathway. Analysis of phosphosites with known function indicate that rotenone activates histone deacetylase-1 and represses the pro-survival transcriptional regulators Mef2C and Mef2D, while inhibiting translation by phosphorylating Eif2b5. These effects do not occur in Lrrk2-/- cultures. This study shows that Lrrk2 is required the earliest rotenone-triggered phospho-signalling events.

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Autophagy in Disease and Therapy Sirtuins and Resveratrol in Medicine

Publication details

Journal / source
bioRxiv (Cold Spring Harbor Laboratory)
Publication date
9 January 2026
Document type
Preprint